Ana Kiess presents results from the RAVENS phase 2 randomized trial, which assessed stereotactic ablative radiotherapy (SABR) with or without radium-223 in oligometastatic prostate cancer. The trial ...

Partial Component Exchange of a Non-Infected Inflatable Penile Prosthesis Is Associated with a Higher Complication Rate - Beyond the Abstract ...

In view of our prior encouraging preclinical study, in this small-scale pilot human study, we showed that 18F-FMAU PET/CT may complement standard of care mpMRI by potentially detecting additional ...

Management of prostate cancer (PCa) patients with lung oligometastases remains unclear in the absence of published data. The aim of this study was to evaluate the efficacy of Stereotactic Body ...

FALCON: A Consensus to guide the future of focal therapy. FALCON aims to provide clear guidance for partial gland ablation in prostate cancer (PCa). After more than 30 years of research, focal therapy ...

Germline testing, next generation sequencing, and the use of PARP inhibitor monotherapy for select patients have been part of our treatment paradigm for patients with metastatic castration-resistant ...

Histopathologic Features and Transcriptomic Signatures Do Not Solve the Issue of Magnetic Resonance Imaging-Invisible Prostate Cancers: A Matched-Pair Analysis - Beyond the Abstract ...

The oncogenic mechanisms by which TFE3 fusion proteins drive translocation renal cell carcinoma (tRCC) are poorly characterized. Here, we integrated loss and gain of function experiments with ...

The α2,3-sialyl N-glycosylated free prostate-specific antigen ratio (S2,3PSA%) was approved in Japan as a prostate cancer (PCa) diagnostic test. We evaluated the analytical characterization and ...

Renal cell carcinoma is frequently discovered at a localized stage in an aging population, which is often frail, comorbid, and unsuitable for surgery. Stereotactic body radiotherapy (SBRT) is gaining ...

Hashim Hashim joins Diane Newman for a conversation on the definitions of lower urinary tract dysfunction and the role and timing of urodynamics in the diagnosis of the specific condition. They also ...

Oliver Sartor discusses the SPLASH trial results, evaluating Lutetium-177-PNT2002 in metastatic castration-resistant prostate cancer patients who progressed on ARPI therapy. The study shows ...